NEWARK, Calif. (AP) _ Protagonist Therapeutics Inc. (PTGX) on Thursday reported a loss of $41 million in its second quarter.
On a per-share basis, the Newark, California-based company said it had a loss of 84 cents.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 99 cents per share.
The biopharmaceutical company posted revenue of $859,000 in the period.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTGX at https://www.zacks.com/ap/PTGX
Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News